Zogenix (ZGNX) Gets FDA Approval of Zohydro ER
January 30, 2015 at 19:11 PM EST
Zogenix, Inc. (Nasdaq:ZGNX), announced that the FDA has approved a new formulation of Zohydro® ER (hydrocodone bitartrate) Extended-Release Capsules, CII, with BeadTek™. BeadTek is a formulation technology designed to provide abuse-deterrent properties without changing the release properties of hydrocodone when Zohydro ER is used as intended. Concurrently, Zogenix has ongoing Human Abuse Liability studies, which […] View the full post at: Zogenix (ZGNX) Gets FDA Approval of Zohydro ER No related posts.